|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.30 BDT | +0.36% |
|
-1.40% | +18.90% |
| Market Cap | 17.44B 141M 124M 114M 105M 199M 13.63B 202M 1.37B 537M 6.67B 531M 519M 22.97B | P/E 2024 |
5.9x | P/E 2025 | 6.29x |
|---|---|---|---|---|---|
| Enterprise Value | 40.31B 327M 286M 265M 243M 459M 31.5B 467M 3.16B 1.24B 15.41B 1.23B 1.2B 53.1B | EV / Sales 2024 |
1.15x | EV / Sales 2025 | 1.06x |
| Free-Float |
55.88% | Yield 2024 |
5.11% | Yield 2025 | 4.85% |
| 1 day | +0.36% | ||
| 1 week | -1.40% | ||
| Current month | +2.31% | ||
| 1 month | +2.68% | ||
| 3 months | +11.51% | ||
| 6 months | +14.85% | ||
| Current year | +18.90% |
| 1 week | 83.1 | 87.5 | |
| 1 month | 79.6 | 88.7 | |
| Current year | 70.6 | 88.7 | |
| 1 year | 68.6 | 88.7 | |
| 3 years | 62.6 | 94.5 | |
| 5 years | 62.6 | 117.7 | |
| 10 years | 54.2 | 122.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 1995-09-29 | |
| Director of Finance/CFO | - | - | |
Asad Shamsuddin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 82 | 1975-03-16 | |
| Director/Board Member | 76 | 1981-04-14 | |
| Chairman | 69 | 2018-09-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.36% | -1.40% | +12.25% | -1.17% | 144M | ||
| -1.75% | -1.59% | +52.60% | +150.76% | 1,051B | ||
| -1.47% | -3.05% | +52.04% | +48.41% | 609B | ||
| -0.44% | +2.11% | +36.99% | +78.09% | 450B | ||
| -0.75% | +0.30% | +29.77% | +21.15% | 330B | ||
| -1.52% | -1.19% | +34.46% | +35.35% | 284B | ||
| -1.70% | -1.82% | +20.99% | +15.74% | 263B | ||
| -0.58% | +1.11% | -20.18% | -40.59% | 223B | ||
| -0.31% | +1.34% | +23.46% | +56.62% | 198B | ||
| -0.64% | +1.69% | +23.40% | +67.14% | 167B | ||
| Average | -0.84% | +0.20% | +26.58% | +43.15% | 357.52B | |
| Weighted average by Cap. | -1.15% | +0.02% | +37.15% | +72.05% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 31.93B 259M 227M 210M 193M 364M 24.95B 370M 2.51B 983M 12.21B 972M 950M 42.06B | 35.94B 291M 255M 236M 217M 409M 28.08B 416M 2.82B 1.11B 13.74B 1.09B 1.07B 47.34B |
| Net income | 2.46B 19.9M 17.45M 16.13M 14.83M 27.98M 1.92B 28.43M 193M 75.59M 939M 74.74M 73.11M 3.24B | 2.43B 19.68M 17.25M 15.95M 14.66M 27.67M 1.9B 28.11M 191M 74.74M 929M 73.9M 72.29M 3.2B |
| Net Debt | 22.18B 180M 158M 146M 134M 253M 17.33B 257M 1.74B 683M 8.48B 675M 660M 29.22B | 22.87B 185M 162M 150M 138M 261M 17.87B 265M 1.8B 704M 8.75B 696M 681M 30.13B |
Employees
9,025
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-19 | BDT 84.30 | +0.36% | 357,746 |
| 26-07-19 | BDT 84.00 | -1.52% | 749,927 |
| 26-07-16 | BDT 85.30 | -1.27% | 920,682 |
| 26-07-15 | BDT 86.40 | -0.46% | 1,276,664 |
| 26-07-14 | BDT 86.80 | -0.12% | 1,312,285 |
- Stock Market
- Stocks
- ACMELAB Stock
Select your edition
All financial news and data tailored to specific country editions
















